The content in this video is intended for viewing by healthcare professionals only. To register to view restricted videos please scroll down this page, click the ‘Register Now’ button and enter your medical or other health professional registration number. Requests to view restricted content are generally approved within 48 hours.

Intranasal Esketamine Clinical Data – Implications for Patients and Clinicians

Posted on :November 21, 2022
Last Updated: November 27, 2022
In this video, Dr Sanil Rege, consultant psychiatrist reviews the key clinical data for intranasal esketamine in the management of treatment-resistant depression including: the onset of action and impact on depression symptoms 24 hours after dosing 28-day response and remission rates sustained response and prevention of relapse safety and tolerability…



Thank you for your interest in viewing this really fascinating compilation of videos.


As these videos contain medical information, they can only be viewed by medical professionals. Please register and await confirmation which should take only 24-48 hours. Once you receive your confirmation email you are all ready to view all the videos in this section now and in the future. Enjoy!

Register Now

If you already have an account! Login